RET Proto-Oncogene—Not Such an Obvious Starting Point in Cancer Therapy
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14215298
Abstract: Simple Summary Rearranged during transfection (RET) is a transmembrane receptor tyrosine kinase that shows targetable mutations and gene fusions in a few types of cancers. Multiple kinase inhibitors, which target RET kinase, show little efficiency… read more here.
Keywords: ret specific; specific inhibitors; kinase; ret ... See more keywords